OMT-28 explained

Width:	300px
Legal Status:	Investigational
Cas Number:	2068826-41-3
Pubchem:	126483508
Iupac Name:	2-[(''Z'')-13-[[2-(Methylamino)-2-oxoacetyl]amino]tridec-8-enoxy]acetic acid
C:	18
H:	32
N:	2
O:	5

OMT-28 is a synthetic analog of omega-3 epoxyeicosatrienoic acids developed for atrial fibrillation.^{[1] [2]}

Notes and References

1. Berlin . Sarah . Goette . Andreas . Summo . Luciana . Lossie . Janine . Gebauer . Alexander . Al-Saady . Naab . Calo . Leonardo . Naccarelli . Gerald . Schunck . Wolf-Hagen . Fischer . Robert . Camm . A.John . Dobrev . Dobromir . Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study . IJC Heart & Vasculature . August 2020 . 29 . 100573 . 10.1016/j.ijcha.2020.100573. free . 32685659 . 7356118 .
2. Dan . Gheorghe-Andrei . Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden . International Journal of Cardiology. Heart & Vasculature . 6 August 2020 . 29 . 100610 . 10.1016/j.ijcha.2020.100610 . 2352-9067. free . 32885033 . 7452524 .